SCHEMBL9822340

SCHEMBL9822340

O=C1CCc2cc(Cl)ccc2C(=O)CCCN1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRD5A1 P18405 3/20 0.51
MAOA P21397 3/20 0.45
MAOB P27338 3/20 0.45
PRKCI P41743 1/20 0.45
PARP10 Q53GL7 2/20 0.43
F7 P08709 1/20 0.43
PARP1 P09874 1/20 0.43
F3 P13726 1/20 0.43
SRD5A2 P31213 2/20 0.42
OR51E2 Q9H255 1/20 0.41
HTT P42858 1/20 0.41
TYMS P04818 1/20 0.40
CASP1 P29466 1/20 0.40
CASP7 P55210 1/20 0.40
HSD17B10 Q99714 1/20 0.40
PARP11 Q9NR21 1/20 0.40
HTR2A P28223 3/20 0.39
HTR2C P28335 3/20 0.39
HTR2B P41595 3/20 0.39
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30051842 0.81 GAA (0.44) SRD5A1MAOAMAOBPRKCIPARP10
SCHEMBL3531650 0.81 GAA (0.44) SRD5A1MAOAMAOBPRKCIPARP10
SCHEMBL5108894 0.80 MAOA (0.61) SRD5A1MAOAMAOBPRKCISRD5A2
SCHEMBL1798900 0.80 MAOA (0.67) SRD5A1MAOAMAOBPRKCISRD5A2
Hydrochloric Acid SCHEMBL28688881 0.80 CASP1 (0.55) SRD5A1MAOAMAOBPRKCIPARP10
SCHEMBL31029247 0.80 CASP1 (0.59) SRD5A1MAOAMAOBPRKCISRD5A2
SCHEMBL28603 0.80 CASP1 (0.59) SRD5A1MAOAMAOBPRKCISRD5A2
SCHEMBL23160447 0.78 PARP10 (0.60) SRD5A1PARP10F7PARP1F3
Aluminum Chloride Anhydrous SCHEMBL28688879 0.75 CASP1 (0.53) SRD5A1MAOAMAOBPRKCISRD5A2
SCHEMBL533885 0.74 MEN1 (0.47) MAOAMAOBPARP10F7PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0230967-B1 BENZAZECINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1991-10-23 EP claimed
US-4732979-A CEREBRAL INSUFFICIENCY HOFFMANN-LA ROCHE INC. (US) 1988-03-22 US claimed
EP-0230967-A2 Benzazecine derivatives F. HOFFMANN-LA ROCHE AG (CH) 1987-08-05 EP claimed
EP-0230967-B1 BENZAZECINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1991-10-23 EP disclosed
US-4957911-A LEARNING ENHANCEMENT HOFFMANN-LA ROCHE INC. (US) 1990-09-18 US disclosed
US-4876340-A Benzazecine derivatives for cognitive and memory functions HOFFMANN-LA ROCHE INC. (US) 1989-10-24 US disclosed
US-4749791-A Benzo[f]quinoline intermediates HOFFMANN-LA ROCHE INC. (US) 1988-06-07 US disclosed
US-4732979-A CEREBRAL INSUFFICIENCY HOFFMANN-LA ROCHE INC. (US) 1988-03-22 US disclosed
EP-0230967-A2 Benzazecine derivatives F. HOFFMANN-LA ROCHE AG (CH) 1987-08-05 EP disclosed